Junya Fukuoka Selected Research

Indicators and Reagents (Reagents)

5/2024	Squamous metaplasia is an indicator of acute exacerbation in patients with usual interstitial pneumonia / idiopathic pulmonary fibrosis.
1/2019	Detection of DNA damage response in nonalcoholic fatty liver disease via p53-binding protein 1 nuclear expression.
7/2015	Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.
1/2014	Prognostic significance of NANOG and KLF4 for breast cancer.
6/2013	Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junya Fukuoka Research Topics

Disease

56	Neoplasms (Cancer) 02/2024 - 10/2004
19	Lung Neoplasms (Lung Cancer) 09/2023 - 10/2004
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 03/2005
12	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2023 - 07/2005
10	Adenocarcinoma of Lung 11/2021 - 07/2004
10	Adenocarcinoma 11/2021 - 02/2007
10	Carcinoma (Carcinomatosis) 01/2021 - 10/2004
7	Carcinogenesis 09/2023 - 01/2006
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 07/2004
6	Idiopathic Pulmonary Fibrosis 05/2024 - 07/2005
6	Neoplasm Metastasis (Metastasis) 11/2020 - 02/2011
5	Stomach Neoplasms (Stomach Cancer) 08/2021 - 07/2011
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2024 - 12/2010
4	Thymoma (Thymic Carcinoma) 04/2023 - 01/2020
4	Bronchiectasis 07/2022 - 01/2013
4	Dyspnea (Shortness of Breath) 01/2020 - 01/2013
4	Disease Progression 05/2019 - 12/2010
4	Connective Tissue Diseases (Connective Tissue Disease) 11/2018 - 01/2013
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2015 - 10/2004
3	Metaplasia 05/2024 - 07/2005
3	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 07/2012
3	Respiratory Insufficiency (Respiratory Failure) 05/2023 - 12/2010
3	Dermatomyositis (Dermatopolymyositis) 03/2023 - 03/2014
3	Melanoma (Melanoma, Malignant) 03/2023 - 04/2013
3	Fibrosis (Cirrhosis) 01/2022 - 12/2011
3	Hyperplasia 01/2021 - 01/2012
3	Breast Neoplasms (Breast Cancer) 08/2018 - 07/2009
3	Esophageal Squamous Cell Carcinoma 01/2017 - 12/2012
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 07/2022 - 07/2005
2	Lymphoma (Lymphomas) 12/2021 - 01/2015
2	Necrosis 11/2021 - 01/2010
2	Infections 02/2021 - 01/2020
2	Human Influenza (Influenza) 02/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2020 - 01/2019
2	Vascular Diseases (Vascular Disease) 01/2020 - 07/2005
2	Cysts 01/2019 - 09/2010
2	Vasculitis (Vasculitides) 01/2018 - 12/2012
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 01/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2017 - 01/2017
2	Lymphatic Metastasis 01/2017 - 04/2013
2	Spontaneous Remission 01/2015 - 12/2010

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
11	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2004
6	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2012
5	Indicators and Reagents (Reagents)IBA 05/2024 - 06/2013
5	Phosphotransferases (Kinase)IBA 02/2021 - 03/2005
5	LigandsIBA 05/2019 - 12/2016
4	AntibodiesIBA 03/2023 - 12/2010
4	AntigensIBA 01/2023 - 06/2012
4	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2004
4	Formaldehyde (Formol)FDA Link 04/2021 - 07/2011
4	pembrolizumabIBA 01/2021 - 12/2018
3	FibrinIBA 05/2024 - 08/2003
3	AutoantibodiesIBA 03/2023 - 12/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2022 - 11/2018
3	AcidsIBA 03/2022 - 06/2015
3	S-1 plus cisplatinIBA 01/2022 - 01/2012
3	ParaffinIBA 04/2021 - 07/2011
3	CarcinogensIBA 01/2021 - 10/2017
3	CollagenIBA 01/2020 - 07/2005
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 01/2013
3	NivolumabIBA 12/2018 - 12/2017
3	ErbB Receptors (EGF Receptor)IBA 08/2013 - 03/2005
2	Transcription Factors (Transcription Factor)IBA 04/2023 - 04/2018
2	Immunoglobulins (Immunoglobulin)IBA 03/2023 - 02/2012
2	Immunoglobulin G (IgG)IBA 03/2023 - 01/2019
2	HABAIBA 07/2022 - 02/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 03/2022 - 01/2014
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2021 - 11/2021
2	Adenosine Triphosphatases (ATPase)IBA 05/2021 - 07/2010
2	CytokinesIBA 01/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2021 - 12/2013
2	PlatinumIBA 01/2021 - 05/2019
2	Immune Checkpoint InhibitorsIBA 05/2019 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2009
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018 - 12/2012
2	Peroxidase (Myeloperoxidase)IBA 01/2018 - 12/2012
2	Phenobarbital (Luminal)FDA Link 09/2017 - 04/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2017
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2017 - 08/2013
2	MicroRNAs (MicroRNA)IBA 02/2014 - 07/2011
2	Desmoglein 3IBA 09/2013 - 02/2007
2	Keratin-5 (Keratin 5)IBA 09/2013 - 02/2012
2	Tyrosine Kinase InhibitorsIBA 08/2013 - 03/2005
2	Gefitinib (Iressa)FDA Link 08/2013 - 01/2011
2	Gemcitabine FDA Link 07/2013 - 02/2011

Therapy/Procedure

23	Therapeutics 05/2023 - 03/2005
15	Drug Therapy (Chemotherapy) 05/2023 - 04/2007
4	Traction 07/2022 - 01/2013
4	Radiotherapy 01/2022 - 04/2007
3	Immunotherapy 02/2024 - 11/2019
2	Extracorporeal Membrane Oxygenation 05/2023 - 01/2019
2	Combination Drug Therapy (Combination Chemotherapy) 01/2022 - 02/2011
2	Chemoradiotherapy 01/2022 - 06/2019
2	Hysterectomy 10/2021 - 09/2010
2	Artificial Respiration (Mechanical Ventilation) 09/2019 - 12/2010
2	Hematopoietic Stem Cell Transplantation 01/2019 - 01/2019
2	Prostatectomy (Retropubic Prostatectomy) 10/2017 - 01/2014
2	Lasers (Laser) 06/2015 - 10/2004